Literature DB >> 33957773

Sustained Dysbiosis and Decreased Fecal Short-Chain Fatty Acids after Traumatic Brain Injury and Impact on Neurologic Outcome.

Oluwasinmisola M Opeyemi1, Matthew B Rogers2, Brian A Firek2, Keri Janesko-Feldman1, Vincent Vagni1, Steven J Mullett3, Stacy G Wendell3, Brittany P Nelson1, Lee Ann New1, Eliana Mariño4, Patrick M Kochanek1,5,6,7, Hülya Bayır1,5,6,7,8, Robert S B Clark1,5,6,7,9, Michael J Morowitz2,10, Dennis W Simon1,5,6,7.   

Abstract

Traumatic brain injury (TBI) alters microbial populations present in the gut, which may impact healing and tissue recovery. However, the duration and impact of these changes on outcome from TBI are unknown. Short-chain fatty acids (SCFAs), produced by bacterial fermentation of dietary fiber, are important signaling molecules in the microbiota gut-brain axis. We hypothesized that TBI would lead to a sustained reduction in SCFA producing bacteria, fecal SCFAs concentration, and administration of soluble SCFAs would improve functional outcome after TBI. Adult mice (n = 10) had the controlled cortical impact (CCI) model of TBI performed (6 m/sec, 2-mm depth, 50-msec dwell). Stool samples were collected serially until 28 days after CCI and analyzed for SCFA concentration by high-performance liquid chromatography-mass spectrometry/mass spectrometry and microbiome analyzed by 16S gene sequencing. In a separate experiment, mice (n = 10/group) were randomized 2 weeks before CCI to standard drinking water or water supplemented with the SCFAs acetate (67.5 mM), propionate (25.9 mM), and butyrate (40 mM). Morris water maze performance was assessed on post-injury Days 14-19. Alpha diversity remained stable until 72 h, at which point a decline in diversity was observed without recovery out to 28 days. The taxonomic composition of post-TBI fecal samples demonstrated depletion of bacteria from Lachnospiraceae, Ruminococcaceae, and Bacteroidaceae families, and enrichment of bacteria from the Verrucomicrobiaceae family. Analysis from paired fecal samples revealed a reduction in total SCFAs at 24 h and 28 days after TBI. Acetate, the most abundant SCFA detected in the fecal samples, was reduced at 7 days and 28 days after TBI. SCFA administration improved spatial learning after TBI versus standard drinking water. In conclusion, TBI is associated with reduced richness and diversity of commensal microbiota in the gut and a reduction in SCFAs detected in stool. Supplementation of soluble SCFAs improves spatial learning after TBI.

Entities:  

Keywords:  gut–brain axis; microbiome; short-chain fatty acids; traumatic brain injury

Mesh:

Substances:

Year:  2021        PMID: 33957773      PMCID: PMC8403202          DOI: 10.1089/neu.2020.7506

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   4.869


  5 in total

1.  Microbiome and Neurotrauma: Emerging Innovations.

Authors:  A Clark; R Zelmanovich; M R Hosseini Siyanaki; M Michel; C Hanna; C Davidson; B Lucke-Wold
Journal:  Neurol Neurother Open Access J       Date:  2022-08-16

Review 2.  Gut Microbiota and Acute Central Nervous System Injury: A New Target for Therapeutic Intervention.

Authors:  Bin Yuan; Xiao-Jie Lu; Qi Wu
Journal:  Front Immunol       Date:  2021-12-24       Impact factor: 7.561

Review 3.  Gastrointestinal Microbiome and Neurologic Injury.

Authors:  Eric J Panther; William Dodd; Alec Clark; Brandon Lucke-Wold
Journal:  Biomedicines       Date:  2022-02-21

4.  Cerebral Intraparenchymal Hemorrhage Changes Patients' Gut Bacteria Composition and Function.

Authors:  Zujian Xiong; Kang Peng; Shaoyu Song; Yongwei Zhu; Jia Gu; Chunhai Huang; Xuejun Li
Journal:  Front Cell Infect Microbiol       Date:  2022-03-16       Impact factor: 5.293

5.  Gut Microbiota Dysbiosis after Traumatic Brain Injury Contributes to Persistent Microglial Activation Associated with Upregulated Lyz2 and Shifted Tryptophan Metabolic Phenotype.

Authors:  Zhipeng Zheng; Shuai Wang; Chenghao Wu; Yang Cao; Qiao Gu; Ying Zhu; Wei Zhang; Wei Hu
Journal:  Nutrients       Date:  2022-08-24       Impact factor: 6.706

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.